Jump to ContentJump to Main Navigation
Show Summary Details
More options …

Diagnosis

Official Journal of the Society to Improve Diagnosis in Medicine (SIDM)

Editor-in-Chief: Graber, Mark L. / Plebani, Mario

Ed. by Argy, Nicolas / Epner, Paul L. / Lippi, Giuseppe / Singhal, Geeta / McDonald, Kathryn / Singh, Hardeep / Newman-Toker, David

Editorial Board: Basso , Daniela / Crock, Carmel / Croskerry, Pat / Dhaliwal, Gurpreet / Ely, John / Giannitsis, Evangelos / Katus, Hugo A. / Laposata, Michael / Lyratzopoulos, Yoryos / Maude, Jason / Sittig, Dean F. / Sonntag, Oswald / Zwaan, Laura


CiteScore 2018: 0.69

SCImago Journal Rank (SJR) 2018: 0.359
Source Normalized Impact per Paper (SNIP) 2018: 0.424

Online
ISSN
2194-802X
See all formats and pricing
More options …

Clinical impact of citrate-containing tubes on the detection of glucose abnormalities by the oral glucose tolerance test

Graziella Bonetti
  • Corresponding author
  • Central Clinical Chemistry Laboratory, A.S.S.T Spedali Civili of Brescia, Piazzale Spedali Civili 1, 25123 Brescia, Italy, Phone: +39 030 3995508, Fax: +39 030 3995646
  • Email
  • Other articles by this author:
  • De Gruyter OnlineGoogle Scholar
/ Davide Giavarina / Mariarosa Carta
Published Online: 2019-03-15 | DOI: https://doi.org/10.1515/dx-2018-0100

Abstract

Background

Plasma glucose levels provide the cornerstone of diabetes evaluation, and so it is crucial that clinical laboratories provide accurate and reliable plasma glucose results. To prevent in vitro glycolysis, citrate is used. Here, we present the first study on the 75-g oral glucose tolerance test (OGTT) using the currently available new citrate-containing tubes in liquid and granular forms and the previous sodium fluoride (NaF) for the diagnosis of carbohydrate metabolism disorders and gestational diabetes mellitus (GDM) according to the American Diabetes Association (ADA) guidelines.

Methods

The 75-g OGTT was performed in 147 volunteers, 83 of whom were pregnant women. Blood was collected in NaF/K3 ethylenediaminetetraacetic acid (EDTA) and NaF/Na2EDTA/citrate in liquid form in tubes in Brescia and in NaF/K2Ox and NaF/Na2EDTA/citrate in granular form in Vicenza. Glucose was measured within 3–4 h from the OGTT. The mean biases were calculated and compared with the desirable bias (<± 2.1%).

Results

OGTT glucose concentrations were higher in citrate tubes when compared to NaF-containing tubes. When citrate tubes were used, GDM increased to 12.5 and 11.7% in Brescia and Vicenza, respectively. Impaired fasting glucose (IFG), impaired glucose tolerance (IGT) and diabetes mellitus (DM) increased to 36.7, 6.7 and 3.4%, respectively, in Brescia. In Vicenza, an increase of 47 and 1.9% in IFG and IGT, respectively, was found.

Conclusions

OGTT glucose measurement in citrate-containing tubes was shown to be more effective than those containing only NaF in diagnosing carbohydrate disorders. This new glycolysis inhibitor seems to be a necessary preanalytical tool for accurate and reliable plasma glucose results.

Keywords: acidification; diabetes mellitus; diagnosis; gestational diabetes mellitus; glycolysis; oral glucose tolerance test; sodium fluoride

References

  • 1.

    Sacks DB, Arnold M, Bakris GL, Bruns DE, Horvath AR, Kirkman MS, et al. Guidelines and recommendations for laboratory analysis in the diagnosis and management of diabetes mellitus. Clin Chem 2011;57:e1–47.CrossrefPubMedWeb of ScienceGoogle Scholar

  • 2.

    The HAPO Study Cooperative Research Group. Hyperglycemia and adverse pregnancy outcomes. N Engl J Med 2008;358:1991–2002.Google Scholar

  • 3.

    Chan A, Swaminathan R, Cockram C. Effectiveness of sodium fluoride as a preservative of glucose in blood. Clin Chem 1989;35:315–7.PubMedGoogle Scholar

  • 4.

    Bonetti G, Carta M, Lapolla A, Miccoli R, Testa R, Mosca A, et al. Correct determination of glycemia in the diagnosis and management of diabetes: recommendations for the optimization of the pre-analytical phase. Nutr Metab Cardiovasc Dis 2019;29:1–3.PubMedCrossrefGoogle Scholar

  • 5.

    Bonetti G, Carta M, Montagnana M, Lo Cascio C, Bonfigli AR, Mosca A, et al. Effectiveness of citrate buffer-fluoride mixture in Terumo tubes as an inhibitor of in vitro glycolysis. Biochemia Medica 2016;26:68–76.PubMedGoogle Scholar

  • 6.

    Carta M, Montagnana M, Lo Cascio C, Bonetti G, Italian joint SIBioC-SIPMeL study group on diabetes mellitus. Glucose sampling: importance of citrate. Ann Clin Biochem 2016;53:715–6.PubMedCrossrefWeb of ScienceGoogle Scholar

  • 7.

    Bonetti G, Cancelli V, Coccoli G, Piccinelli G, Brugnoni D, Caimi L, et al. Which sample tube should be used for routine glucose determination? Prim Care Diabetes 2016;10:227–32.CrossrefPubMedWeb of ScienceGoogle Scholar

  • 8.

    Bonetti G, Carta M. The new Greiner FC-Mix tubes equal the old Terumo ones and are useful as glucose stabilizer after prolonged storage of samples. Biochem Med (Zagreb) 2017;27:030901.CrossrefPubMedGoogle Scholar

  • 9.

    van der Hagen EA, Fokkert MJ, Kleefman AM, Thelen MH, van den Berg SA, Slingerland RJ. Technical and clinical validation of the Greiner FC-Mix glycaemia tube. Clin Chem Lab Med 2017;55:1530–6.Web of SciencePubMedGoogle Scholar

  • 10.

    Daly N, Flynn I, Carroll C, Farren M, Farren M, McKeating A, et al. Impact of implementing preanalytical laboratory standards on the diagnosis of gestational diabetes mellitus: a prospective observational study. Clin Chem 2016;62:387–91.Web of ScienceCrossrefGoogle Scholar

  • 11.

    Giavarina D, Lippi G. A survey on sample matrix and preanalytical management in clinical laboratories. Biochim Clin 2017;41:142–7.Web of ScienceGoogle Scholar

  • 12.

    American Diabetes Association. Standards of medical care. Classification and diagnosis of diabetes. Diabetes Care 2018;41(Suppl 1):S13–28.PubMedGoogle Scholar

  • 13.

    International Association of Diabetes and Pregnancy Study Groups Consensus Panel. International association of diabetes and pregnancy study groups recommendations on the diagnosis and classification of hyperglycemia in pregnancy. Diabetes Care 2010;33:676–82.PubMedWeb of ScienceGoogle Scholar

  • 14.

    Aarsand AK, Diaz-Garzon J, Fernandez-Calle P, Guerra E, Locatelli M, Bartlett WA, et al. The EuBIVAS: within- and between-subject biological variation data for electrolytes, lipids, urea, uric acid, total protein, total bilirubin, direct bilirubin and glucose. Clin Chem 2018;64:1380–93.PubMedWeb of ScienceCrossrefGoogle Scholar

  • 15.

    Festa R, Carta M, Ceriello A, Testa R. Time is glucose, can’t miss gestational diabetes mellitus. Diabetes Technol Ther 2012;14:444–6.CrossrefPubMedGoogle Scholar

  • 16.

    Daly N, Flynn I, Carroll C, Stapleton M, O’Kelly R, Turner MJ. Comparison of citrate-fluoride-EDTA with fluoride-EDTA additives to stabilize plasma glucose measurements in women being screened during pregnancy with an oral glucose tolerance test: a prospective observational study. Clin Chem 2016;62:886–7.PubMedWeb of ScienceCrossrefGoogle Scholar

  • 17.

    Carey RJ, Churcher M, Hughes R, Florkowski CM, Frampton CM, Heenan HF, et al. Will the use of lyophilized citrate tubes lead to the over-diagnosis of diabetes in pregnancy? J Appl Lab Med 2017;1:592–4.CrossrefGoogle Scholar

  • 18.

    Pasqualetti S, Szoke D, Valente M, Panteghini M. Glycolysis inhibition and reliable plasma glucose results: is the clinical impact carefully considered? Clin Chem Lab Med 1995;53:S104.Google Scholar

  • 19.

    Ridefelt P, Akerfelt T, Helmersson-Karlqvist J. Increased plasma glucose levels after change of recommendation from NaF to citrate blood collection tubes. Clin Biochem 2014;47:625–8.CrossrefPubMedWeb of ScienceGoogle Scholar

  • 20.

    Norman M, Jones L. The shift from fluoride/oxalate to acid citrate/fluoride blood collection tubes for glucose testing – the impact upon patients results. Clin Biochem 2014;47: 683–5.CrossrefPubMedGoogle Scholar

  • 21.

    Yoa RG, Rapin JR, Wiernsperger NF, Martinand A, Belleville I. Demonstration of defective glucose uptake and storage in erythrocytes from non-insulin dependent diabetic patients and effect of metformin. Clin Exp Pharmacol Physiol 1993;20:563–7.CrossrefGoogle Scholar

  • 22.

    Saracevic A, Dukic L, Juricic G, Milevoj Kopcinovic L, Mirosevic G, Simundic AM. Various glycolysis inhibitor-containing tubes for glucose measurement cannot be used interchangeably due to clinically unacceptable biases between them. Clin Chem Lab Med 2018;56:236–41.PubMedCrossrefWeb of ScienceGoogle Scholar

About the article

aOn behalf of the Italian joint SIBioC-SIPMeL Study Group on Diabetes Mellitus.


Received: 2018-11-13

Accepted: 2019-02-15

Published Online: 2019-03-15

Published in Print: 2019-11-26


Author contributions: All the authors have accepted responsibility for the entire content of this submitted manuscript and approved submission.

Research funding: None declared.

Employment or leadership: None declared.

Honorarium: None declared.

Competing interests: The funding organization(s) played no role in the study design; in the collection, analysis, and interpretation of data; in the writing of the report; or in the decision to submit the report for publication.


Citation Information: Diagnosis, Volume 6, Issue 4, Pages 377–383, ISSN (Online) 2194-802X, ISSN (Print) 2194-8011, DOI: https://doi.org/10.1515/dx-2018-0100.

Export Citation

©2019 Walter de Gruyter GmbH, Berlin/Boston.Get Permission

Citing Articles

Here you can find all Crossref-listed publications in which this article is cited. If you would like to receive automatic email messages as soon as this article is cited in other publications, simply activate the “Citation Alert” on the top of this page.

[1]
Matthias Orth, Hannes Hawran, Jagadish Ulloor, Kiran Bachhawat, and Lieselotte Lennartz
Practical Laboratory Medicine, 2019, Page e00134

Comments (0)

Please log in or register to comment.
Log in